Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Oct, 27 2025
Feb, 2 2024
Feb, 25 2026
Mar, 12 2026
Sep, 4 2023